Literature DB >> 22969950

Global dysregulation of the chromosome 14q32 imprinted region in uterine carcinosarcoma.

Eric J Devor1, Jillian N DE Mik, Shyam Ramachandran, Michael J Goodheart, Kimberly K Leslie.   

Abstract

Uterine carcinosarcoma (UCS) is a rare but very aggressive cancer of the female reproductive tract with an extremely poor prognosis. With the goal of understanding the role of microRNA (miRNA) dysregulation in these tumors, we profiled the expression of 667 human miRNAs in a panel of eight UCS patients and five benign control primary tissue samples. These expression profiles revealed two important characteristics of UCS. First, compared with the two most common uterine cancers, endometrial endometrioid adenocarcinoma and endometrial serous adenocarcinoma, UCS samples display a virtually unique pattern of miRNA dysregulation with an overlap of only 5% among the three tumor types. In addition, nearly one-third of the miRNAs significantly dysregulated in UCS tissues compared with benign endometrium (32 of 114) lie in a single small (250-kb) imprinted region of chromosome 14q32. These data suggest that the presence of such a global, region-specific disruption substantially contributes to the unique histology and poor outcome of this type of cancer.

Entities:  

Year:  2012        PMID: 22969950      PMCID: PMC3438812          DOI: 10.3892/etm.2012.458

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  31 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain.

Authors:  Hervé Seitz; Hélène Royo; Marie-Line Bortolin; Shau-Ping Lin; Anne C Ferguson-Smith; Jérôme Cavaillé
Journal:  Genome Res       Date:  2004-08-12       Impact factor: 9.043

3.  Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31.

Authors:  Florian Haller; Anja von Heydebreck; Jitao David Zhang; Bastian Gunawan; Claus Langer; Giuliano Ramadori; Stefan Wiemann; Ozgür Sahin
Journal:  J Pathol       Date:  2010-01       Impact factor: 7.996

4.  microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs.

Authors:  Eric J Devor; Adriann M Hovey; Michael J Goodheart; Shyam Ramachandran; Kimberly K Leslie
Journal:  Oncol Rep       Date:  2011-07-01       Impact factor: 3.906

5.  MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.

Authors:  Alessandro Salvi; Cristiano Sabelli; Silvia Moncini; Marco Venturin; Bruna Arici; Paola Riva; Nazario Portolani; Stefano M Giulini; Giuseppina De Petro; Sergio Barlati
Journal:  FEBS J       Date:  2009-04-16       Impact factor: 5.542

6.  Carcinosarcomas (malignant mullerian mixed tumors) of the uterus and ovary: a genetic study with special reference to histogenesis.

Authors:  Zhe Jin; Shinya Ogata; Gen Tamura; Yousei Katayama; Masayuki Fukase; Mihoko Yajima; Teiichi Motoyama
Journal:  Int J Gynecol Pathol       Date:  2003-10       Impact factor: 2.762

7.  Genomic aberrations in carcinomas of the uterine corpus.

Authors:  Francesca Micci; Manuel R Teixeira; Lisbeth Haugom; Gunnar Kristensen; Vera M Abeler; Sverre Heim
Journal:  Genes Chromosomes Cancer       Date:  2004-07       Impact factor: 5.006

8.  Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia.

Authors:  Amanda Dixon-McIver; Phil East; Charles A Mein; Jean-Baptiste Cazier; Gael Molloy; Tracy Chaplin; T Andrew Lister; Bryan D Young; Silvana Debernardi
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

9.  Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells.

Authors:  Lukas Vrba; Taylor J Jensen; James C Garbe; Ronald L Heimark; Anne E Cress; Sally Dickinson; Martha R Stampfer; Bernard W Futscher
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

10.  Structural conservation versus functional divergence of maternally expressed microRNAs in the Dlk1/Gtl2 imprinting region.

Authors:  Martin Kircher; Christoph Bock; Martina Paulsen
Journal:  BMC Genomics       Date:  2008-07-23       Impact factor: 3.969

View more
  7 in total

1.  Post-transcriptional Regulation of MMP16 and TIMP2 Expression via miR-382, miR-410 and miR-200b in Endometrial Cancer.

Authors:  Beata Rak; Dawid Mehlich; Filip Garbicz; Zofia Domosud; Wiktor Paskal; Janina M Marczewska; Paweł K Włodarski
Journal:  Cancer Genomics Proteomics       Date:  2017 Sep-Oct       Impact factor: 4.069

2.  Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study.

Authors:  Eric J Devor; Jeffrey Miecznikowski; Brandon M Schickling; Jesus Gonzalez-Bosquet; Heather A Lankes; Premal Thaker; Peter A Argenta; Michael L Pearl; Susan L Zweizig; Robert S Mannel; Amy Brown; Nilsa C Ramirez; Olga B Ioffe; Kay J Park; William T Creasman; Michael J Birrer; David Mutch; Kimberly K Leslie
Journal:  Gynecol Oncol       Date:  2017-09-29       Impact factor: 5.482

3.  MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma.

Authors:  Liron Zehavi; Hagit Schayek; Jasmine Jacob-Hirsch; Yechezkel Sidi; Raya Leibowitz-Amit; Dror Avni
Journal:  Mol Cancer       Date:  2015-03-26       Impact factor: 27.401

Review 4.  MicroRNA Regulation of Brain Tumour Initiating Cells in Central Nervous System Tumours.

Authors:  Neha Garg; Thusyanth Vijayakumar; David Bakhshinyan; Chitra Venugopal; Sheila K Singh
Journal:  Stem Cells Int       Date:  2015-05-03       Impact factor: 5.443

5.  Plasma microRNA panel for minimally invasive detection of breast cancer.

Authors:  Katarina Cuk; Manuela Zucknick; Dharanija Madhavan; Sarah Schott; Michael Golatta; Jörg Heil; Frederik Marmé; Andrey Turchinovich; Peter Sinn; Christof Sohn; Hans Junkermann; Andreas Schneeweiss; Barbara Burwinkel
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

Review 6.  An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report.

Authors:  Debora de Melo Gagliato; Rudinei Diogo Marques Linck; Regis Otaviano Franca Bezerra; Mirela Souto; Gabriel Lima Lopes; Glauco Baiocchi; Max Senna Mano
Journal:  J Med Case Rep       Date:  2016-03-14

7.  Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?

Authors:  Laura Gonzalez Dos Anjos; Bruna Cristine de Almeida; Thais Gomes de Almeida; André Mourão Lavorato Rocha; Giovana De Nardo Maffazioli; Fernando Augusto Soares; Isabela Werneck da Cunha; Edmund Chada Baracat; Katia Candido Carvalho
Journal:  Cancers (Basel)       Date:  2018-09-06       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.